DIAVERUM FACILITIES MANAGEMENT LIMITED

Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Accounting basis

FRS 102

Reporting scope

Standalone (parent only)

Auditor

Deloitte LLP

Audit opinion

Unqualified (clean)

Going concern

Affirmed

“Notwithstanding net current liabilities of £28,899,054 as at 31 December 2024 (despite a profit for the year then ended of £5,310,259), the financial statements have been prepared on the going concern basis which the directors consider to be appropriate for the following reasons. The directors have prepared cash flow forecasts for the Company for the purposes of assessing going concern. On a standalone basis, the Company will have sufficient funds to meet its liabilities as they fall due for 12 months from the signing of these financial statements. Whilst the entity is not dependent on ongoing support from its indirect parent, Diaverum AB, has provided a letter of support confirming that it will continue to provide financial and other support to the Company for a period of twelve months from the date of approval of these financial statements if necessary to enable the preparation of consolidated financial statements under the going concern assumption. The directors have also satisfied that it has the ability and intention to be able to provide this support.”

Significant events

• “The Company signed updated facility agreements with a parent undertaking on 1st April 2025 (effective 1st January 2025), which increased the facility from £27 million to £31 million. The overall facility across Diaverum UK Limited and Diaverum Holding UK Limited remained the same (£100M), but the allocation was updated based on current borrowing levels and anticipated future borrowing levels.”
• “Diaverum exited the Norwich and Cromer clinics on the 1st of March 2025, after a competitive tender exercise where we were unsuccessful in retaining the contract”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

Filings

4

last 12 months

Capital events

0

last 24 months

Officers appointed

0

last 12 months

Officers resigned

1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

• Turnover

  +12.6%

  £31,133,041 → £35,047,508

• Cash

  0%

  £94,600 → £94,600

• Net assets

  +48.6%

  -£10,916,397 → -£5,606,138

• Employees

  0%

  66 → 66

• Operating profit

  +149.7%

  -£16,449,438 → £8,168,922

• Profit before tax

  +141.4%

  -£18,133,234 → £7,510,973

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers